Drugs / AdGVPEDF.11D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00109499 | — | macular degeneration | GenVec | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdGVPEDF.11D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00109499 ↗ |
| Route | Intravitreal | “AdGVPEDF.11D will be delivered once via intravitreal injection into one eye.” NCT00109499 ↗ |